Literature DB >> 23735167

Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis.

A Aghamohammadi1, Z Gholizadeh Moghaddam2, H Abolhassani2, Z Hallaji3, H Mortazavi3, S Pourhamdi2, P Mohammadinejad2, N Rezaei4.   

Abstract

BACKGROUND: Primary immunodeficiency diseases (PIDs) are a group of heterogeneous inherited disorders, characterised by recurrent infections, autoimmunity and malignancy. Some PIDs such as hyper IgE syndrome (HIES) and Wiskott-Aldrich syndrome (WAS) may be initially presented as atopic dermatitis (AD), especially in its severe form, resulting in diagnostic delay and poor prognosis of patients.
OBJECTIVE: The aim of this study was to evaluate the frequency of PIDs among patients with severe AD and to determine factors that can help to raise suspicion towards these disorders.
METHODS: Seventy-five patients with a well-established diagnosis of severe AD were enrolled in this study. Initial immunological evaluations, including humoral and cellular investigation, were performed in all individuals. Patients underwent further investigations in a case of suspicion of a probable PID.
RESULTS: Among all patients with severe AD, five (6.6%) were diagnosed with HIES and one (1.3%) with WAS. Family history of PIDs, family history of death in early infancy, positive history of recurrent infections such as skin and respiratory infections, otitis media and sinusitis were observed significantly higher in patients with a diagnosis of PID.
CONCLUSIONS: The presence of an underlying PID could explain the poor prognosis and refraction to the treatment of some patients with severe AD. Several clinical and laboratory findings can help the physicians to focus towards PIDs which are more serious. Delay in diagnosis of PID cases with skin manifestation of AD without proper management may result in lower quality of life and higher morbidity and mortality rates.
Copyright © 2012 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Hyper IgE syndrome; Wiskott–Aldrich syndrome

Mesh:

Year:  2013        PMID: 23735167     DOI: 10.1016/j.aller.2013.02.004

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  5 in total

1.  Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.

Authors:  Asghar Aghamohammadi; Payam Mohammadinejad; Hassan Abolhassani; Babak Mirminachi; Masoud Movahedi; Mohammad Gharagozlou; Nima Parvaneh; Vaheid Zeiaee; Bahram Mirsaeed-Ghazi; Zahra Chavoushzadeh; Alireza Mahdaviani; Mahboubeh Mansouri; Sedigheh Yousefzadegan; Bahareh Sharifi; Fariborz Zandieh; Ehsan Hedayat; Ali Nadjafi; Roya Sherkat; Behzad Shakerian; Mahnaz Sadeghi-Shabestari; Reza Farid Hosseini; Farahzad Jabbari-Azad; Hamid Ahanchian; Fatemeh Behmanesh; Mohammadreza Zandkarimi; Afshin Shirkani; Taher Cheraghi; Abbas Fayezi; Iraj Mohammadzadeh; Reza Amin; Soheila Aleyasin; Mojgan Moghtaderi; Javad Ghaffari; Saba Arshi; Naser Javahertrash; Mohammad Nabavi; Mohammad Hassan Bemanian; Alireza Shafiei; Najmedin Kalantari; Akefeh Ahmadiafshar; Hossein Ali Khazaei; Lida Atarod; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05       Impact factor: 8.317

2.  Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients.

Authors:  Fadime Ceyda Eldeniz; Yahya Gul; Alaaddin Yorulmaz; Sukru Nail Guner; Sevgi Keles; Ismail Reisli
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

Review 3.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

4.  Cutaneous Manifestations of Primary Immunodeficiency Diseases in Tunisian Children.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Imen Ben-Mustapha; Ridha Kouki; Habib Besbes; Mohamed Ridha Barbouche; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

5.  Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency.

Authors:  Saeed Bazregari; Gholamreza Azizi; Marzieh Tavakol; Mohammad Hosein Asgardoon; Fatemeh Kiaee; Naeimeh Tavakolinia; Amir Valizadeh; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Cent Eur J Immunol       Date:  2017-12-30       Impact factor: 2.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.